## Abstract It cannot be disputed that inβhouse (βhome brewβ) assays have a part to play in the diagnosis of emerging or evolving infections such as avian influenza H5N1. In such circumstances, diagnostic companies can provide Research Use Only (RUO) or analyte specific reagents (ASR) to facilitate
Comparison of commercial and in-house immunoblot assays for the rapid diagnosis ofMycoplasma pneumoniaeinfection
β Scribed by Nevio Cimolai
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 146 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1341-321X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract There are no differences inherent in the design of commercial or inβhouse assays and their early development is similar. The same principles apply and it is on the same criteria of accuracy, reproducibility and clinical relevance of results that all assays are judged. However, if there
Eight commercially available enzymelinked immunoadsorbent assays (ELISA) for the detection of cytomegalovirus (CMV)specific IgM were used in parallel to determine the presence of CMV-IgM in 123 serum samples from pregnant women. The results obtained with the eight kits were compared. Based on concor